Boosting Medical Readiness: Review of US Biopharmaceutical Manufacturing
This Act aims to enhance public health security by reviewing and improving the nation's capacity to manufacture essential biopharmaceutical products. This means that in the event of future health crises, the United States will be better prepared to rapidly produce necessary medical supplies, reducing reliance on foreign sources. Consequently, citizens can expect a faster and more reliable response to health threats.
Key points
Review of Domestic Capacity: The Secretary of Health and Human Services will commission a review of the current US capacity for biopharmaceutical manufacturing.
Improving Threat Preparedness: The goal is to increase the adaptability of drug production in the face of various health threats and crises.
New Technologies: Recommendations will be drafted for deploying new manufacturing technologies to fill gaps and enhance the security of medical supplies.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.